(Q46630321)

23 December 2017

title

Pulmonary gemcitabine delivery for treating lung cancer: pharmacokinetics and acute lung injury aspects in animals (English)

1 reference

23 December 2017

1 reference

Rui Min

1

1 reference

23 December 2017

Ting Li

2

1 reference

23 December 2017

Ju Du

3

1 reference

23 December 2017

Yan Zhang

4

1 reference

23 December 2017

Jia Guo

5

1 reference

23 December 2017

Wan-Liang Lu

6

1 reference

23 December 2017

publication date

1 May 2008

1 reference

23 December 2017

Canadian Journal of Physiology and Pharmacology

published in

1 reference

23 December 2017

volume

86

1 reference

23 December 2017

issue

5

1 reference

23 December 2017

page(s)

288-298

1 reference

23 December 2017

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study

cites work

1 reference

Delivery options and devices for aerosolized therapeutics

21 January 2018

1 reference

Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome

21 January 2018

1 reference

Pulmonary distribution of particles given by intratracheal instillation or by aerosol inhalation

21 January 2018

1 reference

Drug delivery via the respiratory tract

21 January 2018

1 reference

Anti-apoptotic PTD-FNK protein suppresses lipopolysaccharide-induced acute lung injury in rats

21 January 2018

1 reference

Emerging protein delivery methods

21 January 2018

1 reference

Pharmacokinetics of gemcitabine and its primary metabolite in dogs after intravenous bolus dosing and its in vitro pharmacodynamics

21 January 2018

1 reference

Oral vinorelbine given as monotherapy to advanced, elderly NSCLC patients: a multicentre phase II trial

21 January 2018

1 reference

The bacterial metabolite 2,3-butanediol ameliorates endotoxin-induced acute lung injury in rats.

21 January 2018

1 reference

Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs

21 January 2018

1 reference

Intrapulmonary administration of insulin to healthy volunteers.

21 January 2018

1 reference

A phase II study with gemcitabine and split-dose cisplatin in patients with advanced non-small cell lung cancer

21 January 2018

1 reference

High-performance liquid chromatographic method for the determination of gemcitabine and 2',2'-difluorodeoxyuridine in plasma and tissue culture media.

21 January 2018

1 reference

Study on pulmonary delivery of salmon calcitonin in rats: effects of protease inhibitors and absorption enhancers

21 January 2018

1 reference

An overview of current results with the gemcitabine and docetaxel combination as initial and salvage chemotherapy regimen in advanced non-small cell lung cancer.

21 January 2018

1 reference

Severe acute lung injury induced by gemcitabine.

21 January 2018

1 reference

Patient preferences for oral versus intravenous palliative chemotherapy

21 January 2018

1 reference

Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group

21 January 2018

1 reference

Biological markers of acute lung injury: prognostic and pathogenetic significance

21 January 2018

1 reference

In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery

21 January 2018

1 reference

The inhalers of the future? A review of dry powder devices on the market today

21 January 2018

1 reference

Chemotherapy in the elderly: pharmacologic considerations

21 January 2018

1 reference

Clinical detection of LPS and animal models of endotoxemia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1139/Y08-039

1 reference

23 December 2017

1 reference

23 December 2017